Suppr超能文献

高剂量局部应用阿米替林治疗神经病理性疼痛:两例病例报告及文献复习。

High doses of topical amitriptyline in neuropathic pain: two cases and literature review.

机构信息

Institute for Neuropathic Pain, Soest, The Netherlands.

出版信息

Pain Pract. 2012 Feb;12(2):148-53. doi: 10.1111/j.1533-2500.2011.00477.x. Epub 2011 Jun 16.

Abstract

Severe chronic neuropathic pain is a challenge to treat, and due to adverse effects of classical oral medication, optimal and effective dose levels are difficult to reach. Therefore, administration of topical analgesics might be an option, due to reduced adverse effects, and increased patient compliance. The aim of this article is to describe two cases treated effectively with topical amitriptyline 5% and 10%, the highest dosage described to date. The first patient was a 39-year-old man, suffering from severe intractable neuropathic pain in feet and hands, due to diabetes mellitus type II (DM-II). After application of amitriptyline 5% the patient experienced a complete relieve only in the hands, whereas after application of amitriptyline 10%, a total reduction of pain occurred within 20 minutes, lasting the whole day. The second patient was a 57-year-old man, suffering for 10 years from progressive sensory disturbances in both feet and increasing pain due to chronic idiopathic axonal polyneuropathy (CIAP). Amitriptyline 5% cream reduced pain in the toes nearly completely, but this was not the case in the heels. Amitriptyline 10% reduced pain in the feet, however, systemic adverse effects occurred, mainly drowsiness. The patient decided to stop topical treatment because of these adverse effects. These two cases suggest an analgesic dose-response effect of topical amitriptyline in painful neuropathy. Systemic adverse effects should be taken into account.

摘要

严重的慢性神经性疼痛是一种治疗挑战,由于经典口服药物的不良反应,很难达到最佳和有效的剂量水平。因此,由于不良反应减少和患者依从性增加,局部镇痛药的给药可能是一种选择。本文的目的是描述两例用 5%和 10%的外用阿米替林治疗有效的病例,这是迄今为止描述的最高剂量。第一例患者是一名 39 岁男性,患有 II 型糖尿病(DM-II)引起的严重难治性周围神经性疼痛。应用 5%的阿米替林后,患者仅在手部完全缓解疼痛,而应用 10%的阿米替林后,疼痛在 20 分钟内完全减轻,持续一整天。第二例患者是一名 57 岁男性,患有 10 年的双侧足部进行性感觉障碍和慢性特发性轴索性多发性神经病(CIAP)引起的疼痛增加。5%的阿米替林乳膏几乎完全减轻了脚趾疼痛,但脚跟并非如此。10%的阿米替林减轻了脚部疼痛,但出现了全身不良反应,主要是嗜睡。由于这些不良反应,患者决定停止局部治疗。这两个病例提示外用阿米替林在神经性疼痛中存在镇痛剂量反应效应。应考虑全身不良反应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验